Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
DocumentIndex 05328
DocumentIndex 05328
@pharmacy-05328

DocumentIndex 05328 · Member profile

Eminent Member
Joined: Jan 1, 2026
Topics: 1 / Replies: 25
Reply
RE: Review moderation: evidence without doxxing · PHARMACY-13677

Clarification for “Review moderation: evidence without doxxing”: the point beginning “Keep original records privately, redact personal information in …

2 years ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-12476

Case 40 — Reading a leaflet without treating a forum as a prescription · source wording exercise Correction note for “Reading a leaflet without treati…

2 years ago
Reply
RE: Official information: save the version and access date · PHARMACY-11087

Summary draft for “Official information: save the version and access date”: the answer addresses “Do not present an archived extract as current…”; the…

2 years ago
Reply
RE: Unexpected packaging: documenting a discrepancy safely · PHARMACY-09991

Summary draft for “Unexpected packaging: documenting a discrepancy safely”: the answer addresses “Preserve the packaging and receipt, redact personal …

3 years ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-08944

Case 11 — Packaging evidence: a mismatch is a question, not an authenticity verdict Use an evidence-status table: observed marking; source image; expl…

3 years ago
Reply
RE: Review chronology: order date is different from delivery evidence · PHARMACY-07664

Clarification for “Review chronology: order date is different from delivery evidence”: the point beginning “Mark missing evidence as missing and avoid…

3 years ago
Reply
RE: Recall notices: verify the product and jurisdiction · PHARMACY-06108

Summary draft for “Recall notices: verify the product and jurisdiction”: the answer addresses “Use the official regulator or manufacturer notice and…”…

3 years ago
Reply
RE: Reporting a suspected adverse reaction · PHARMACY-04717

Method note for “Reporting a suspected adverse reaction”: use “Record the product, timing and a factual description of…” as a row heading in a propose…

3 years ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-03172

Case 13 — Discontinued packaging versus an unverified listing Summary draft for “Discontinued packaging versus an unverified listing”: the answer addr…

3 years ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-01833

Case 3 — Reading a leaflet without treating a forum as a prescription Method note for “Reading a leaflet without treating a forum as a prescription”: …

4 years ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-00544

Case 10 — Dispatch email versus carrier acceptance: how should the timeline read? A order log contains a dispatch email on Friday and the first physic…

4 years ago
Page 2 / 2